With half the global incidence of cancer, Asia is facing a challenge that will put enormous stress on healthcare systems. This stress will be felt not only in developed countries in the region but increasingly in the less developed nations. Most governments recognise the coming cancer challenge in Asia and are developing national cancer control plans which set out the strategic public health response to the disease.
This report, Controlling cancer: The state of national cancer control plans in Asia, commissioned by Mundipharma and written by the Economist Intelligence Unit (EIU), seeks to assess in a qualitative manner the extent and efficacy of such plans. It also aims to identify best practices that might be shared to improve control plans.
Controlling cancer: Mundipharma and EIU’s report on the state of national cancer control plans in Asia: